BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 19 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | -33.3% | 2,540 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 2,540 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -33.3% | 2,540 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | 0.0% | 2,540 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | -14.3% | 2,540 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | -30.0% | 2,540 | 0.0% | 0.00% | – |
| Q1 2021 | $10,000 | +42.9% | 2,540 | 0.0% | 0.00% | – |
| Q4 2020 | $7,000 | -95.0% | 2,540 | -29.6% | 0.00% | – |
| Q3 2020 | $141,000 | +80.8% | 3,607 | +4.9% | 0.00% | – |
| Q2 2020 | $78,000 | +188.9% | 3,440 | -1.0% | 0.00% | – |
| Q1 2020 | $27,000 | +237.5% | 3,475 | +286.1% | 0.00% | – |
| Q4 2019 | $8,000 | +60.0% | 900 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | 0.0% | 900 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | 0.0% | 900 | 0.0% | 0.00% | – |
| Q1 2019 | $5,000 | +25.0% | 900 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | -20.0% | 900 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | -16.7% | 900 | 0.0% | 0.00% | – |
| Q2 2018 | $6,000 | +20.0% | 900 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|